highly significantP < 0.0001
However, over the course of 6 months post-second dose, 111/113 (98.5%) LTCH staff exhibited highly significant decays ( P < 0.0001) in anti-spike and anti-RBD IgG antibody levels with approximate half-lives of 63 (31–73) days and 57 (28–71) days, respectively, ( Fig. 5A through F ).